- Home
- ATCH vs KZR Comparison
ATCH vs KZR Comparison
Compare ATCH & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCH | KZR |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2M | 45.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ATCH | KZR |
|---|---|---|
| Price | $0.25 | $6.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 4.2M | 29.9K |
| Earning Date | 02-18-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,303,120.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.78 | N/A |
| 52 Week Low | $0.14 | $3.53 |
| 52 Week High | $15.27 | $6.93 |
Technical Indicators
Market Signals| Indicator | ATCH | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 52.34 |
| Support Level | $0.25 | $6.22 |
| Resistance Level | $0.27 | $6.35 |
| Average True Range (ATR) | 0.02 | 0.10 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 0.89 | 40.91 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.